UBS 'quality and undervalued' mid-caps list includes no UK stocks

UBS's latest HOLT screen of SMID stocks, which ranks names by operational quality, recent CFROI revisions and relative undervaluation, highlights Crocs, Maximus and K92 Mining among 20 top-tier picks drawn from 113 qualifying companies — notably with no London-listed stocks included — reflecting a heavier US, Canadian and Japanese representation and a wider-than-usual valuation gap between SMID and large caps. The pool of qualifiers rose from 86 a year ago, underscoring improved underlying performance or cheaper valuations, and UBS warns that SMID discounts are near historic highs on its market-implied yield metric. Michel Lerner notes broad underperformance of historically high-quality stocks (about 70% lagging) has compressed their HOLT economic PE premium to near-decade lows, creating “fallen angel” opportunities where quality is now attractively valued and CFROI headwinds are easing, even as momentum-favored quality outperformers trade at premiums last seen in the dotcom era — a dynamic that suggests selective quality exposure with improving CFROI may offer asymmetric risk/reward for investors.

Analysis

UBS's latest HOLT SMID screen identified 113 qualifying companies and ranked 20 top-tier names based on operational quality, three-month CFROI revisions and relative undervaluation; highlighted stocks include Crocs (CROX), Maximus (MMS) and K92 Mining (KNT.V), and notably no London-listed companies made the top 20. The pool of qualifiers increased from 86 a year ago, indicating either improved underlying performance or cheaper valuations, and the selections were concentrated in the US, Canada and Japan with a handful of European exceptions such as Finland’s Valmet.

UBS flagged that the valuation discount between SMID and large-cap stocks is near historic highs on its market-implied yield metric, and HOLT’s head Michel Lerner noted roughly 70% of historically high-quality stocks have underperformed this year, compressing their HOLT economic PE premium to its lowest level in nearly a decade. Lerner describes a subset of "fallen angels" where quality is now attractive even versus longer-term references while other quality outperformers command PE premiums last seen in the dotcom era and the HOLT discount rate sits at record lows.

Investment implications are therefore twofold: selective SMID exposure to names showing improving CFROI and HOLT undervaluation may offer asymmetric returns, but the market currently rewards momentum and has created stretched premiums for quality leaders. Investors should monitor CFROI revisions, HOLT economic PE and market-implied yield metrics as well as regional dispersion (UK SMID underperformance) and interest-rate/bond-yield dynamics that UBS cites as the structural backdrop for valuation divergence.

Key Decisions for Investors

• Perform targeted due diligence on UBS's top-20 HOLT picks (e.g., CROX, MMS, KNT) and consider selective overweight positions only in SMID stocks with recent positive CFROI revisions and clear HOLT undervaluation
• Reduce broad exposure to London-listed SMID allocations for now and reallocate consideration toward US, Canadian and Japanese SMID names where the screen shows concentration and relative value
• Monitor HOLT economic PE premium, market-implied yield and three-month CFROI revisions as primary go/no-go indicators and limit position sizes or use hedges because momentum is favouring winners and quality leaders trade at historically high premiums
• Watch interest-rate and bond-yield moves closely since UBS highlights the changing bond-yield backdrop as a structural driver of quality stock valuation differentials; be prepared to trim or hedge if discount rates rise